|New Online Course Offers Insight into the Importance of Sex
and Gender Differences in Human Health
Bethesda, Maryland — The National Institutes of Health
(NIH) Office of Research on Women’s Health (ORWH), in collaboration with the
Food and Drug Administration (FDA) Office of Women’s Health (OWH), announces
the launch of a new online course, “The Science of Sex and Gender in Human Health.” The
course offers participants a basic scientific understanding of the major physiological
differences between the sexes, their influence on illness and health outcomes,
and their implications for policy, medical research, and health care.
“Understanding the potential contribution of sex and gender factors in health
and disease and in morbidity and mortality is critical to the public health and
important for the design of research studies and their clinical implications,” said
Vivian Pinn, M.D., Director of NIH ORWH.
“This online course will be an excellent resource for investigators and clinicians,
ensuring a better understanding of sex and gender differences,” said Kathleen
Uhl, M.D., Assistant Commissioner for FDA OWH.
Designed for researchers, clinicians, members of academia, and students in health
professional schools, this course was created to emphasize the importance of
looking at the roles of sex and gender in clinical research and treatment and
builds upon the Institute of Medicine (IOM) report, “Exploring the Biological
Contributions to Human Health: Does Sex Matter,” issued in 2001 for which NIH
and FDA were co-funders.
This course, which is free to the public, is self-paced and consists of six
lessons that cover definitions of sex and gender; the development and implementation
of applicable Federal guidelines and regulations; cell physiology; developmental
biology; pharmacodynamics and pharmacokinetics; and clinical applications of
genomics. The course is accessible at http://sexandgendercourse.od.nih.gov/index.aspx.
This activity has been approved for AMA PRA Category 1 Credit ™.
Other participants who complete the course will receive a certificate from the
NIH. A second module, which will apply the basic concepts presented in this course
to specific conditions and organ systems where sex differences play a significant
role, is in development.
For more information about NIH’s Office of Research on Women’s Health, visit http://orwh.od.nih.gov/.
For more information about FDA’s Office of Women’s Health, go to http://www.fda.gov/womens/.
The Food and Drug Administration (FDA) is a science-based agency that protects
and advances consumers’ health by regulating $1 trillion worth of products
a year — the entire US food supply, except for meat and poultry; medical
devices and all radiation-emitting equipment, biological products, including
vaccines, blood products and tissues for transplantation; and cosmetics. For
more information about FDA, visit http://www.fda.gov/.
The National Institutes of Health (NIH) — The Nation's Medical Research
Agency — includes 27 Institutes and Centers and is a component of
the U.S. Department of Health and Human Services. It is the primary federal
agency for conducting and supporting basic, clinical and translational medical
research, and it investigates the causes, treatments, and cures for both common
and rare diseases. For more information about NIH and its programs, visit www.nih.gov.